1Eiichi O.Effect of a novel free radical scavenger,Edaravone (MCI-186),on acute brain infarction[J].Cerebrovasc Dis,2003,15 (3):222-229.
2Zhang N,Komine-Kobayashi M,Tanaka R,et al.Edaravone rduces early accumulation of oxidative products and sequential inflammtory responses after transient focal ischemia in mice brain[J].Stroke,2005,36 (10):2220-2225.
3Wen J,Watanabe K,Ma M,et al.Edaravone inhibits JNK-cJun pathway and restores anti-oxidative defense after ischemia-reperfusion injury in aged rats[J].Biol Pharm Bull,2006,29(4):713-718.
4Nakamura H,Uzura M,Uchida K,et al.Effects of edaravone on experimental brain injury in view of free radical reaction[J].Acta Neurochir Suppl,2003,86:309-311.
6Banno M,Mizuno T,Kato H,et al.The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia[J].Neuropharmacology,2005,48(2):283-290.
7Yano M,Okuda S,Oda T,et al.Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure[J].Circulation,2005,112(23):3633-3643.
8Ishizawa M,Mizushige K,Noma T,et al.An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model[J].Life Sci,2006,78 (25):2974-2982.
10Tsujita K,Shimomura H,Kawano H,et al.Effects of edaravone on reperfusion injury in patients with acute myocardial infarction[J].Am J Cardiol,2004,94(4):481-484.
3[2]Tanakam M.Pharmacological and clinical profile of the free radical scavebger edaravone as a neuroprotedtice agent.Nippon Yakurigaku Zasshi,2002,119:301~303